Zobrazeno 1 - 10
of 12
pro vyhledávání: '"R K, Sterling"'
Publikováno v:
Journal of viral hepatitis. 19(2)
This study assessed the association of HIV RNA with indirect markers of liver injury including FIB-4 index, liver enzymes and platelet counts in a high-risk Hispanic population. The data were derived from a prospective study that included 138 HIV/hep
Autor:
K K, Snow, H L, Bonkovsky, R J, Fontana, H-Y, Kim, R K, Sterling, A M, Di Bisceglie, T R, Morgan, J L, Dienstag, M G, Ghany
Publikováno v:
Alimentary pharmacologytherapeutics. 31(7)
Primary analysis of the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) Trial showed long-term peginterferon therapy did not reduce complications in patients with chronic hepatitis C and advanced fibrosis or cirrhosis.To assess t
Autor:
G T, Everson, M L, Shiffman, T R, Morgan, J C, Hoefs, R K, Sterling, D A, Wagner, C C, Kulig, T M, Curto, E C, Wright, Maria, Mihova
Publikováno v:
Alimentary pharmacologytherapeutics. 27(9)
The spectrum of functional impairment in patients with compensated chronic hepatitis C is incompletely defined.To define hepatic impairment by quantitative tests (quantitative liver function tests) and correlate results with disease severity in patie
Publikováno v:
Alimentary pharmacologytherapeutics. 26(3)
Measurement of portal inflow and portal-systemic shunt using cholate clearances could be useful in monitoring patients with liver disease.To examine relationships of cholate clearances and shunt to cirrhosis and varices and to define minimal sampling
Autor:
R K, Sterling, J J, Salvatori, V A, Luketic, A J, Sanyal, A S, Fulcher, R T, Stravitz, M J, Contos, A S, Mills, M L, Shiffman
Publikováno v:
Alimentary pharmacologytherapeutics. 20(9)
Ursodeoxycholic acid has been ineffective in the treatment of primary sclerosing cholangitis. Because the pathogenesis of primary sclerosing cholangitis is related to immune destruction of bile duct epithelium, several immune suppressive agents have
Autor:
R K, Sterling, R A, Fisher
Publikováno v:
Clinics in liver disease. 5(2)
Liver transplantation is now accepted as effective therapy in the treatment of acute and chronic hepatic failure. Improvements in surgical techniques and immune suppression have led to 5-year survival rates that exceed 70% in most centers. The succes
Autor:
R K, Sterling
Publikováno v:
Gastrointestinal endoscopy clinics of North America. 11(1)
Gastrointestinal complications and diseases are common in liver transplant recipients. One must have a working knowledge of gastrointestinal disorders that existed before and de novo disease that occurs after transplantation. It is important to separ
Autor:
M L, Shiffman, C M, Hofmann, J, Gabbay, V A, Luketic, R K, Sterling, A J, Sanyal, M J, Contos, M J, Ryan, C, Yoshida, V, Rustgi
Publikováno v:
The American journal of gastroenterology. 95(10)
The present study was designed to evaluate the effectiveness of interferon-ribavirin combination therapy for treatment of chronic hepatitis C virus (HCV) in patients who failed previous treatment with interferon monotherapy.A total of 140 patients wi
Autor:
A, Marcos, R A, Fisher, J M, Ham, M L, Shiffman, A J, Sanyal, V A, Luketic, R K, Sterling, A S, Fulcher, M P, Posner
Publikováno v:
Transplantation. 69(7)
Regeneration of the liver to a predetermined size after resection or transplantation is a well described phenomenon, but the time course over which these events occur has not been well defined. It is not clear how initial liver mass, reperfusion, imm
Publikováno v:
The American journal of gastroenterology. 92(10)
Patients infected with HIV frequently have abnormal results on liver tests, leading to radiographic evaluation for hepatic lesions. The etiology of these lesions in patients infected with HIV is most often secondary to infections or tumors. Occasiona